First-pass extracted concept

designer cell therapy

Candidate: concept label1 source documents4 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

Designer cell therapy uses engineered therapeutic cells with information-processing abilities to recognize abnormalities and respond by delivering therapeutic factors. The review frames this as a modality extending beyond standard CAR T-cell behavior.

Source 1DOI PubMed

What problem it solves

It aims to overcome shortcomings of CAR T cells and broaden therapeutic-cell function, including use in solid tumors and tissue regeneration.

Source 1DOI PubMed

Alternatives

The abstract contrasts therapeutic cells with conventional drugs such as small molecules and biologics.

Source 1DOI PubMed

Evidence Snippets

Various types of designer cells have been developed and tested to overcome the shortcomings of CAR T cells and expand their functions in the treatment of solid tumors.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1primary paper2024MEDDOI PubMed

1 evidence snippet 4 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1application capabilitysupports2024Source 1DOI PubMed

The information-processing capability of therapeutic cells enables targeted delivery of therapeutic factors to specific locations and times.

Quoted textsource-backed

This capability enables the targeted delivery of therapeutic factors to specific locations and times.

Claim 2engineering rationalesupports2024Source 1DOI PubMed

Designer cells have been developed and tested to overcome shortcomings of CAR T cells and expand functions for treatment of solid tumors.

Quoted textsource-backed

Various types of designer cells have been developed and tested to overcome the shortcomings of CAR T cells and expand their functions in the treatment of solid tumors.

Claim 3functional capabilitysupports2024Source 1DOI PubMed

Therapeutic cells possess cellular information processing abilities that allow them to recognize and respond to abnormalities in the body.

Quoted textsource-backed

Therapeutic cells differ significantly from conventional drugs, such as small molecules and biologics, as they possess cellular information processing abilities to recognize and respond to abnormalities in the body.

Claim 4translational potentialsupports2024Source 1DOI PubMed

Synthetic receptor-based designer-cell technologies have strong potential for medical applications in regenerating damaged tissues that are difficult to cure with conventional drugs.

Quoted textsource-backed

Such technologies demonstrate great potential for medical applications to regenerate damaged tissues as well that are difficult to cure with conventional drugs.